# FDA Inspection 1219616 - BioStem Life Sciences - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/biostem-life-sciences/de55e7e3-8385-47a6-a7e2-115a7f378976
Source feed: FDA_Inspections

> FDA Inspection 1219616 for BioStem Life Sciences on September 15, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219616
- Company Name: BioStem Life Sciences
- Inspection Date: 2023-09-15
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1291328 - 2025-09-26](https://www.keypedia.com/records/fda_inspections/biostem-life-sciences/ef58b3f5-efda-4ae7-972f-0fe44c2d3324)
- [FDA Inspection 1055502 - 2018-06-13](https://www.keypedia.com/records/fda_inspections/biostem-life-sciences/083c516d-ed06-4889-a482-5bcc6361e7fe)

Company: https://www.keypedia.com/companies/biostem-life-sciences/8bd5184b-7fa5-4821-8bdd-5fae8be6fe62

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d